Tuberous Sclerosis Complex with Subependymal Giant Cell Astrocytoma

DBCOND0025535Congenital, Hereditary, and Neonatal Diseases and Abnormalities Eye Disease

Tuberous Sclerosis Complex with Subependymal Giant Cell Astrocytoma is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Classified under: Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Eye Disease
Neoplasms
Neoplasms, Glandular and Epithelial
Nervous System Diseases
Signs and Symptoms
Skin and Subcutaneous Tissue Diseases
Skin and subcutaneous tissue disorders congenital NEC
Indicated drugs: Everolimus

What you can answer from here — as of November 01, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

Which approved drugs for Tuberous Sclerosis Complex with Subependymal Giant Cell Astrocytoma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account